To further validate ISVS, we applied it for screening of a cohort of Polish NSHL patients with the aim to identify and characterize pathogenic TMPRSS3 mutations in this population. This evidence concerns the gene TMPRSS3 and nodular sclerosis classical Hodgkin lymphoma.